Navigation Links
DOW Chemical at the World Drug Delivery & Formulation Summit 2013
Date:12/10/2012

LONDON, December 10, 2012 /PRNewswire/ --

The pharmaceutical industry is experiencing a massive paradigm shift as the era of the highly profitable blockbusters comes to a close. In an attempt to remain competitive, companies are under more pressure than ever to push novel compounds through the development pipeline and so it has been largely left to those in formulation and delivery to optimise their product portfolio using winning business strategies and leading technologies.

Entering its 4th consecutive year, the World Drug Delivery & Formulation Summit informs attendees of leading industry updates, strategies and technologies through technical workshops, case studies and presentations. It equips delegates with the tools and the know-how they need to launch new products, reformulate existing drugs and to remain both patient and regulatory compliant.  

The three day summit is structured into three distinct streams that focus on leading issues and challenges in the small molecule, biological and technology space respectively. These include innovative formulation technologies, routes of delivery, advances in drug delivery devices and best practices in supporting the sourcing and management of partnering relationships.

We are thrilled that Dow Chemical will be attending both as our Lead Category Sponsor for Solubilisation and as Chairman for our leading technology day. We look forward to hearing from them during their interactive session on Monday 18th February 2013.

Exclusive sessions include:

  • Preventing the Demise of the Research-driven Pharmaceutical Industry Model
  • Driving Development in Extreme Population Groups - Geriatrics & Paediatrics
  • Evolving Controlled Release Technologies to Support the Next Generation of Drug Delivery
  • Novel Concepts in Pharmaceutical Analysis in Supporting Formulation
  • Understanding and Developing the Science Behind Oral Protein Delivery
  • Optimising the Delivery of Peptide Therapeutics
  • Adopting Open Innovation to Ensure Continued Growth and Success in Pharma Development  

For the full programme, visit http://www.ddfevent.com/programme.

This summit agenda is researched and produced with the help of drug delivery and formulation experts to reflect the latest industry news, technologies and advancements. Additionally we facilitate pre-arranged one-to-one meetings onsite between yourselves and leading service and technology providers, hand-picked to suit your personal needs.

World Trade Group is a leading global integrated media company that organises and operates leading annual business events within the HR, energy, pharmaceutical, food and beverage, manufacturing and supply chain sectors.

http://www.worldtradegroup.com/

For more information, visit http://www.ddfevent.com; contact Michaela Melcher on michaela.melcher@wtgevents.com or call +44(0)207-202-7690.


'/>"/>
SOURCE World Trade Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
2. ChemAxon Announces New Version of chemicalize.org for Tablet PCs
3. ESTEVE Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program
4. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
5. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
6. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
7. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
8. Premier Healthcare Alliance Awards 3-Year Group Purchasing Contract for Diaper and Adult Brief Waste Receptacles to Sinclair Worldwide
9. U.S. News & World Report and Pharmacy Times Introduce New Pharmacist-recommended Health Product Website
10. AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
11. Philips transforms care to address the economic challenges faced by radiology departments and radiologists worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 2016  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... 2016. First Quarter 2016 Highlights , ... or "Cash Flow") of $13.6 million for the first ... $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 ... BVXV) announced today that BiondVax,s CEO, Dr. Ron Babecoff ... in New York City . ... 10:30am at Pioneers 2016, a conference presented by Joseph ... Palace Hotel. The BiondVax presentation that Dr. Babecoff ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
Breaking Medicine Technology:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... From May ... Chicago, IL, offering EarQ members the unique opportunity to learn more about Signia’s technology ... independent practice growth. , “It is our priority to see practices succeed in this ...
(Date:5/6/2016)... San Diego, CA (PRWEB) , ... May 06, 2016 , ... ... of Companies, has been family-owned and operated for over 35 years. Maintaining core values ... community has driven their success and made them a leading name in San Diego ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... and David Konur, CEO of Cardiovascular Institute of the South announced today that ... performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... overall select performance in the industry’s gold standard KLAS Performance Report, ... Epic Consulting report assessed organizations that specialize in consulting services for electronic health ...
(Date:5/5/2016)... ... May 05, 2016 , ... Florida Hospital Pepin ... atrial fibrillation (A-Fib) an alternative to long-term warfarin medication with the newly approved ... April of 2015, Florida Hospital Pepin Heart Institute doctors successfully implanted the Watchman ...
Breaking Medicine News(10 mins):